Can a Full-Body scan and blood test spot cancer early? new study aims to find out

NCT ID NCT05868486

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at whether whole body MRI scans and liquid biopsies (blood tests) are acceptable to people with a strong family history of cancer. Researchers want to see if these tools can help find early-stage cancers that standard screenings might miss. The study involves 100 participants and focuses on how satisfied they are with the process, not yet on whether the tests actually detect cancer.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Whole body MRI and liquid biopsy
What this could lead to
If successful, this could show that combining whole body MRI and liquid biopsies is a feasible way to detect early cancers in high-risk individuals, potentially leading to earlier diagnosis.
What could go wrong
This is a very early feasibility study with only 100 participants. It measures patient satisfaction, not cancer detection rates, so it may not prove these tests actually find cancers earlier or save lives.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEMATOPOIETIC AND LYMPHOID SYSTEM NEOPLASM are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • City of Hope Medical Center

    Duarte, California, 91010, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.